July 29, 2015 — Teams at the Willis-Knighton Cancer Center in Shreveport, Louisiana, have achieved high levels of quality care, ease of use and speed of treatment in 11 months on IBA’s Proteus One compact proton therapy system.
After a record-setting 11 month installation with patient treatment beginning in September 2014, the Willis-Knighton team continues to set new records by employing a compact proton therapy system that treats clinically with pencil beam scanning (PBS). In addition to treating more common indications such as the brain and prostate, PBS has accelerated their ramp speed by enabling new applications such as breast, head and neck, esophageal lung, spine cancer, pediatric malignancies and various pelvis indications.
By working together with IBA, the Willis Knighton team is currently averaging 15 minutes per patient for most indications, even with multiple fields, resulting in a daily volume of 20 patients per eight-hour day. They expect that volume to increase based upon the even faster treatment times and expanded applications that Advanced Image Guidance with cone beam computed tomography (CBCT) will bring them. IBA’s Cone Beam CT is the only volumetric imaging solution to have obtained marketing authorization by the U.S. Food and Drug Administration (FDA) and is in clinical use daily.
Lane R. Rosen, M.D., director of radiation oncology at the Willis-Knighton Cancer Center, added: “The Proteus One has exceeded all of our expectations. We are very excited to have intensity modulated proton therapy and cone beam CT imaging available for our patients. Both Willis-Knighton and IBA teams have been partnering at each step to ensure a smooth transition from installation to first treatment and beyond during the ramp-up of operations. We have met or exceeded all of our expectations with this collaboration and are looking forward to even more treatment options for our patients in the future"
For more information: www.iba-worldwide.com
March 28, 2024 
